Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community (2015)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- Subjects: QUIMIOTERAPIA (EFEITOS ADVERSOS); NEOPLASIAS COLORRETAIS (TERAPIA); TOXICIDADE
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 33, n. 3S , abstr. 760, 2015
- Conference titles: Gastrointestinal Cancers Symposium
-
ABNT
PROTASIO, Bruno Mendonca et al. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b. Acesso em: 22 jan. 2026. , 2015 -
APA
Protasio, B. M., Matutino, A. R. B., Lage, L. V., De Santana, I. A., Ramos, R. E. D. O., Caires-Lima, R., et al. (2015). Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b -
NLM
Protasio BM, Matutino ARB, Lage LV, De Santana IA, Ramos REDO, Caires-Lima R, Caires IQDS, Riechelmann RP, Saragiotto DF, Sabbaga J, Hoff PM. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2026 jan. 22 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b -
Vancouver
Protasio BM, Matutino ARB, Lage LV, De Santana IA, Ramos REDO, Caires-Lima R, Caires IQDS, Riechelmann RP, Saragiotto DF, Sabbaga J, Hoff PM. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2026 jan. 22 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b - A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
- Palliative chemotherapy in patients with malignant bowel obstruction
- Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?
- Is surgery always necessary in rectal cancer?
- Estudo epidemiológico de pacientes com adenocarcinoma colorretal submetidos à ressecção do primário: descrição de 212 pacientes operados no Instituto do Câncer do Estado de São Paulo - ICESP
- Uso de sorafenibe em pacientes com carcinoma hepatocelular (CHC) Child-Pugh B: análise retrospectiva de onze pacientes
- Liga de Oncologia da Faculdade de Medicina da Universidade de São Paulo (FMUSP): experiência de 13 anos
- Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
- Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity
- Revisão de processos reduz tempo de implementação de estudos clínicos no Instituto do Câncer do Estado de São Paulo
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
